CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.137
https://www.valueinhealthjournal.com/article/S1098-3015(23)03267-9/fulltext
Title :
CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03267-9&doi=10.1016/j.jval.2023.09.137
First page :
Section Title :
Open access? :
No
Section Order :
10818